These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 18945573

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
    Li J, Chen J, Zheng G, Liao G, Fu Z, Li J, Zhang T, Su Y.
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
    [Abstract] [Full Text] [Related]

  • 4. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
    Spence J, Krings T, TerBrugge KG, Agid R.
    Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
    Kishi K, Morita N, Terada T, Sato M.
    Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
    [Abstract] [Full Text] [Related]

  • 7. Ethanol sclerotherapy of peripheral venous malformations.
    Rimon U, Garniek A, Galili Y, Golan G, Bensaid P, Morag B.
    Eur J Radiol; 2004 Dec; 52(3):283-7. PubMed ID: 15544907
    [Abstract] [Full Text] [Related]

  • 8. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation.
    Lee BB, Kim DI, Huh S, Kim HH, Choo IW, Byun HS, Do YS.
    J Vasc Surg; 2001 Apr; 33(4):764-72. PubMed ID: 11296330
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations.
    Yang Y, Sun M, Ma Q, Cheng X, Ao J, Tian L, Wang L, Lei D.
    J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632
    [Abstract] [Full Text] [Related]

  • 12. Comparative outcomes for sclerotherapy of head and neck venous vascular malformation between alcohol and bleomycin.
    Songsaeng D, Churojana A, Khumthong R, Mahiwan L.
    J Med Assoc Thai; 2015 Apr; 98(4):408-13. PubMed ID: 25958717
    [Abstract] [Full Text] [Related]

  • 13. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
    Yun WS, Kim YW, Lee KB, Kim DI, Park KB, Kim KH, Do YS, Lee BB.
    J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A clinical study of ultrasound-guided intralesional injection of bleomycin A5 on venous malformation in cervical-facial region in China.
    Hou R, Guo J, Hu K, Yang Y, Wang L, Kong L, Liu G, Lei D.
    J Vasc Surg; 2010 Apr; 51(4):940-5. PubMed ID: 20347690
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bleomycin Foam Treatment of Venous Malformations: A Promising Agent for Effective Treatment with Minimal Swelling.
    Ul Haq F, Mitchell SE, Tekes A, Weiss CR.
    J Vasc Interv Radiol; 2015 Oct; 26(10):1484-93. PubMed ID: 26164845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.